0

Meaningful use guidance for the Cancer Registry

Onboarding process

  1. Registration
    Eligible providers wishing to onboard for cancer reporting must register their intent to attest by completing the Meaningful Use Registration Form. If eligible providers want to report to the cancer registry without attesting for Meaningful Use, they should email the Cancer Registry Manager at  cdphe_cancer_mu@state.co.us

  2. Pre-testing
    The onboarding providers will review the vocabulary and messaging standards and reporting requirements. They'll generate and validate test messages using a standard tool, submitting the results to us.

  3. Initial submission
    Once your agency is ready to generate messages with the required standards, a test message will be sent using one of the secure methods. We'll validate this HL7 CDA message. Completion of Step 3 meets meaningful use Stage 1 attestation requirements.

  4. Validation
    Once your HL7 CDA message has been validated and a secure method of transfer has been successfully tested, ongoing production-level data will be transferred from your system on at least a monthly basis. These messages will be evaluated for vocabulary standards. The reports received will be matched against disease reports received from your facility from traditional methods.

  5. Production and ongoing validation
    Once we're satisfied that your decision engine is appropriately flagging and reporting all reportable conditions, we'll certify your feed and move your cancer feed into production. At this time, your facility can cease its previous method of cancer reporting.

Onboarding facilities should allow nine to 12 months to complete this process.

If eligible providers want to report to the cancer registry without attesting for Meaningful Use, they should email the Cancer Registry Manager at  cdphe_cancer_mu@state.co.us

Messaging and vocabulary standards

  • Standards for new feeds are the same as meaningful use Stage 2 requirements.

  • Messaging standard: HL7 CDA R2.

Guidance